Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Beadle

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|January 6, 2005
Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitroCaroll B Hartline, Kortney M Gustin, William B Wan, et al.
Antiviral Chemistry & Chemotherapy|July 5, 2001
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infectionsK Y Hostetler, R J Rybak, J R Beadle, et al.
Biochemical Pharmacology|June 15, 1997
Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitroK Y Hostetler, J R Beadle, G D Kini, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cellsJ R Beadle, G D Kini, K A Aldern, et al.
Investigative Ophthalmology & Visual Science|January 31, 2002
Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovirLingyun Cheng, Karl Y Hostetler, Sunan Chaidhawangul, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Anti-BK virus activity of nucleoside analogsParmjeet Randhawa, Jiri Zemlicka, Andreas Sauerbrei, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic culturesIlya Lebeau, Graciela Andrei, Fabiana Dal Pozzo, et al.
Bioorganic & Medicinal Chemistry|April 16, 2011
Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenineJacqueline Ruiz, James R Beadle, R Mark Buller, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonatesMark N Prichard, Caroll B Hartline, Emma A Harden, et al.
Molecular Vision|March 10, 2011
Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferationJiangping Hou, Yuli Li, Zhonglou Zhou, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|January 6, 2005
Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitroCaroll B Hartline, Kortney M Gustin, William B Wan, et al.
Antiviral Chemistry & Chemotherapy|July 5, 2001
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infectionsK Y Hostetler, R J Rybak, J R Beadle, et al.
Biochemical Pharmacology|June 15, 1997
Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitroK Y Hostetler, J R Beadle, G D Kini, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cellsJ R Beadle, G D Kini, K A Aldern, et al.
Investigative Ophthalmology & Visual Science|January 31, 2002
Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovirLingyun Cheng, Karl Y Hostetler, Sunan Chaidhawangul, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Anti-BK virus activity of nucleoside analogsParmjeet Randhawa, Jiri Zemlicka, Andreas Sauerbrei, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic culturesIlya Lebeau, Graciela Andrei, Fabiana Dal Pozzo, et al.
Bioorganic & Medicinal Chemistry|April 16, 2011
Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenineJacqueline Ruiz, James R Beadle, R Mark Buller, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonatesMark N Prichard, Caroll B Hartline, Emma A Harden, et al.
Molecular Vision|March 10, 2011
Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferationJiangping Hou, Yuli Li, Zhonglou Zhou, et al.
Pageof 9